Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02400112 · ClinicalTrials.gov registry record · Phase 4
Local Application of Vancomycin Powder in Grade I-IIIA Open Fractures
A Phase 4 study, sponsored by University of Tennessee.
- Terminated
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT02400112 is a Phase 4 study that was terminated before completion, run by University of Tennessee. The registered enrollment target is 11 participants.
The verdict
NCT02400112, a Phase 4 study, was terminated before completion, sponsored by University of Tennessee.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if local administration of vancomycin powder at the site of Grade I-IIIA open fractures at the time of surgery will be an efficacious method to lower infection rates in open fracture treatment and to elucidate any detrimental effects of applying vancomycin powder at the site of open fractures.
Interventions
- DRUG Vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02400112
The ClinicalTrials.gov registry entry for NCT02400112 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vancomycin is the first listed.
NCT02400112 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02400112 about?
NCT02400112 is a clinical study titled "Local Application of Vancomycin Powder in Grade I-IIIA Open Fractures". The purpose of this study is to determine if local administration of vancomycin powder at the site of Grade I-IIIA open fractures at the time of surgery will be an efficacious method to lower infection rates in open fracture treatment and to elucidate any detrimental effects of applying vancomycin p...
What is the current status of trial NCT02400112?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2015-03. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02400112?
The interventions under investigation include: Vancomycin (DRUG).
Who is sponsoring clinical trial NCT02400112?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.